, , , , , , , ,


New Jersey Health Foundation (NJHF) has awarded a $50,000 Innovation Grant to Mark C. Siracusa, PhD, to advance his work in the regulation of mast cell development, announced James M. Golubieski, president.

Dr. Siracusa is an assistant professor in the Department of Medicine and Center for Immunity and Inflammation at Rutgers New Jersey Medical School.  In 2014 when he joined New Jersey Medical School he earned the distinction of being the first Rutgers Biomedical and Health Sciences Chancellor’s Scholar, a university-wide appointment that recognizes and supports exemplary new faculty members.  

Encouraging results obtained by Dr. Siracusa using a $35,000 Research Grant from NJHF to advance his preliminary work led to this most recent award. 

He will use the $50,000 Innovation Grant to advance his studies on the regulation of mast cell development to treat a variety of diseases, including mast cell leukemia, allergic inflammation and parasitic infections.

Read more here.